Scientific evidence
A tissue systems pathology assay for high-risk Barrett’s esophagus
May 2016
Exploration of a tissue systems pathology approach to predict progression in patients with non-dysplastic Barrett's esophagus.
Publication: Cancer Epidemiology, Biomarkers & Prevention
A tissue systems pathology test detects a field effect associated with high-grade dysplasia and esophageal cancer in Barrett’s esophagus patients
May 2016
TissueCypher better predicts the presence of HGD and EAC in BE than pathologic variables and can improve histology to identify patients requiring therapy.
Publication: Poster presentation (Sa1257) at DDW 2016, San Diego
A cost-effectiveness analysis of a test that predicts risk of malignant progression in Barrett’s esophagus
May 2016
TissueCypher is cost-saving after five years and improves patient outcomes due to improving the effectiveness of surveillance and treatment.
Publication: Podium presentation (CN4) at ISPOR 2016, Washington DC
A tissue systems pathology test detects a field effect associated with high grade dysplasia and esophageal cancer in Barrett’s esophagus patients
May 2016
TissueCypher better predicts presence of HGD and EAC in BE than pathologic variables, and can improve on histology to identify patients requiring therapy.
Publication: Poster presentation (Sa1257) at DDW 2016, San Diego
A novel tissue systems pathology test predicts progression in Barrett’s esophagus patients
Apr 2016
TissueCypher better predicts progression in BE than clinicopathologic variables, and can improve on histology as a method to risk stratify patients with BE.
Publication: Podium presentation (301) at DDW 2016, San Diego
A cost-effectiveness analysis of a cancer risk prediction test for patients with Barrett’s esophagus
Apr 2016
The individualized risk prediction test has the potential to improve the efficiency of endoscopic surveillance in BE and to enable early intervention as needed.
Publication: Poster presentation (Sa 1261) at DDW 2016, San Diego
A novel tissue systems pathology test predicts progression in Barrett’s esophagus patients
Apr 2016
TissueCypher better predicts progression in BE than clinicopathologic variables, and can improve on histology as a method to risk stratify patients with BE.
Publication: Podium presentation (301) at DDW 2016, San Diego
TissueCypher: a systems biology approach to anatomic pathology
Dec 2015
A quantitative, multiplexed biomarker imaging approach termed TissueCypher™ that applies systems biology to anatomic pathology.
Publication: Journal of Pathology Informatics